ASP announced its largest enriched silicon-28 supply contract to date, with deliveries to a US customer expected in Q1 2026. The company also acquired a radiopharmacy in Florida to expand PET Labs, its SA radiopharmaceutical subsidiary, marking its first move into the US market. The deal is expected to be accretive to 2026 revenue, EBITDA, and EPS.
Click here to read the SENS